Business context and reporting period
This is Schweitzer-Mauduit International, Inc.’s unaudited Form 10-Q for the quarter ended March 31, 2011; the filing does not identify Mativ Holdings, Inc. as the registrant. The company produced specialty papers and reconstituted tobacco products, with tobacco-related products representing at least 94% of sales. It reported two product-line segments: Paper and Reconstituted Tobacco, following a segment reporting change in Q1 2011.
Financial results and liquidity
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Net sales | $180.7 million | $192.8 million |
| Gross profit / margin | $47.2 million / 26.1% | $53.5 million / 27.7% |
| Operating profit / margin | $26.4 million / 14.6% | $31.0 million / 16.1% |
| Continuing operations income | $16.6 million | $19.8 million |
| Net income | $16.2 million | $18.6 million |
| Diluted EPS | $0.91 | $1.02 |
| Cash from operations | $(0.2) million | $31.4 million |
| Capital spending | $27.7 million | $9.9 million |
Cash and equivalents were $77.2 million at March 31, 2011, down from $87.3 million at year-end 2010. Total debt was $110.7 million, versus $51.8 million; long-term debt was $101.5 million. Total debt to capital rose to 17.6% from 9.0%. The company reported $39.0 million of U.S. revolver availability, 55 million euros of Euro Revolver availability (about $78.0 million), and $29.6 million available under overdraft facilities. It was in compliance with debt covenants. The quarterly dividend was $0.15 per share.
Material changes versus prior year
- Sales fell 6.3%, driven by unfavorable product mix and selling prices (a $4.9 million impact), lower volume ($4.5 million), and currency ($2.7 million). Total unit volume declined 7.7%; Paper volume fell 6.1% and Reconstituted Tobacco volume fell 10.0%.
- Gross profit declined $6.3 million. Higher inflationary costs, including wood pulp and energy, reduced results by $6.2 million; unfavorable currency and product mix also weighed. Savings initiatives and lower restructuring costs partly offset these pressures.
- Paper operating profit increased to $10.2 million from $9.2 million, while Reconstituted Tobacco operating profit declined to $20.0 million from $25.9 million.
- Operating cash flow weakened by $31.6 million year over year, mainly reflecting a $26.5 million working-capital cash use versus a $5.2 million source in the prior-year quarter. Inventory rose to $124.2 million from $113.8 million.
- The company repurchased 803,337 shares for $45.8 million and drew on its U.S. revolver. It recorded $56.1 million in long-term debt proceeds.
Outlook, commentary, risks and unusual items
Management expected 2011 performance to benefit from European lower-ignition-propensity (LIP) paper demand ahead of EU requirements beginning in November 2011. Commercial orders and start-up had begun at the new Poland facility; Q2 was expected to include both start-up and initial commercial sales. Management expected Reconstituted Tobacco results to remain near Q1 levels for the rest of 2011, while inflation in energy and pulp remained an earnings pressure. It anticipated selling-price adjustments would begin to provide some recovery later in the year. Total 2011 capital spending was forecast at $55–$75 million.
- Construction of the Philippines reconstituted tobacco leaf facility was suspended after a major customer reduced expected needs and the leaf tobacco sector faced volatility and oversupply. Assets under construction were $69.9 million; the company recorded no impairment at March 31, 2011. It expected to spend a further $30–$35 million in 2011 to bring the facility to a mothballed state.
- Brazilian value-added tax credits totaled $16.1 million. If government action to accelerate their use is unsuccessful, the company said it may need an allowance for a significant portion.
- A Brazilian tax assessment totaled about $36 million, of which about $17 million was subject to seller indemnification. No liability was recorded because management believed the company was more likely than not to prevail.
- Philip Morris USA disputed about $24.4 million of payments under a banded-paper cost-plus contract. The company recorded no provision and warned an unfavorable resolution could materially affect results.
- Patent oppositions, re-examinations and U.S. litigation concerning LIP products were ongoing. The filing describes procedural uncertainty; the company stated these matters would not prevent production and sale of its Alginex LIP solution.
- Other stated risks included customer concentration (the three largest customers represented 45% of 2010 sales), tobacco demand and regulation, raw-material and energy inflation, foreign exchange, and environmental claims.
Management reported effective disclosure controls as of March 31, 2011 and no material change in internal control over financial reporting during the quarter. The filing states that Q1 results are not necessarily indicative of full-year results.
Important facts for investors to verify
- Confirm the issuer and period: this filing is for Schweitzer-Mauduit International, Inc., not Mativ Holdings, Inc.
- Track European LIP order growth, launch costs and the expected earnings contribution, alongside continued inflation and pricing adjustments.
- Assess the Philippines project’s remaining suspension costs, asset recoverability and any change in customer demand.
- Monitor working-capital trends, capital spending, debt growth, share repurchases and covenant headroom.
- Follow the Brazilian tax-credit utilization effort, the tax assessment appeal and the Philip Morris USA payment dispute for changes in exposure or recorded reserves.